Alliance Pharmaceutical will kick off its marketing campaign for ultrasound contrast agent Imagent June 9 at the annual meeting of the American Society of Echocardiography in Orlando. The commercial release follows recent FDA approval of the agent to
Alliance Pharmaceutical will kick off its marketing campaign for ultrasound contrast agent Imagent June 9 at the annual meeting of the American Society of Echocardiography in Orlando. The commercial release follows recent FDA approval of the agent to opacify the left ventricle in patients with suboptimal echocardiograms. Imagent, formerly known as Imavist, will be marketed by Alliance in partnership with Cardinal Health and inChord Communications. Imagent is manufactured from synthetic materials and packaged as a dry powder in a ready-to-use kit stored at room temperature. The powder is reconstituted with water to form an osmotically stabilized suspension of microscopic spheres, or microspheres, containing a perfluorochemical (perflexane) vapor and physiologic gases. Imagent is then injected intravenously into a patient undergoing a cardiac ultrasound exam.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.